Healthcare resource use and costs for people with type 2 diabetes mellitus with and without severe mental illness in England: Longitudinal matched-cohort study using the Clinical Practice Research Datalink

Accepted/In Press date: 17 August 2021

Published date: 21 September 2021

Additional Information: Funding Information: S.A. has received funding from the Wellcome Institutional Strategic Support Fund and a National Institute of Health Research (NIHR) Clinical Trials Fellowship. S.A. is a member of the Health Services & Delivery Research funding committee. S.G. is deputy chair of the NIHR Health Technology Assessment (HTA) Commissioning Board, and a member of the HTA Commissioning Committee, the HTA Funding Committee Policy Group, and the HTA Post-Funding Committee teleconference. C.H. is a member of the NIHR HTA Commissioning Board (2015-current). R.I.G.H. has received honoraria for speaker engagement, conference attendance or advisory boards from: AstraZeneca, Boehringer-Ingelheim, European Association for the Study of Diabetes, Eli Lilly, Janssen, Menarini, Mylan, Novo Nordisk and Omniamed, Otsuka. R.I.G.H. was a member of the HTA Prioritisation Committee C (Mental Health, Women and Children's Health) until July 2019. D.S. is an expert advisor to the National Institute for Health and Care Excellence (NICE) centre for guidelines; a Board member of the National Collaborating Centre for Mental Health (NCCMH); a Clinical Advisor (paid consultancy basis) to the National Clinical Audit of Psychosis (NCAP); these are the personal views of D.S. and not those of NICE, NCCMH or NCAP. D.S. has received personal fees from Wiley Blackwell publication ‘Promoting Recovery in Early Psychosis’ 2010, ISBN 978-1-4051-4894-8, joint editor in receipt of royalties, outside the submitted work; personal fees received as member of the current NICE guideline development group for Rehabilitation in adults with complex psychosis and related severe mental health conditions. N.S. is a member of the British Journal of Psychiatry editorial board but did not take part in the review or decision-making process of this paper. H.-I.W., L.H., R.J., S.L.P., T.D., J.T., C.E.W.K. and S.B. declare no conflicts of interest. Funding Information: This publication presents independent research funded by the National Institute for Health Research (NIHR) Health Services and Delivery Research (HS&DR) programme (ref 15/70/26). S.G., N.S., S.L.P. and R.J. were also funded by the NIHR Yorkshire and Humber Applied Research Collaboration (NIHR YH-ARC), https://www.arc-yh.nihr.ac.uk/ . The views expressed are those of the authors and not necessarily those of the HS&DR programme, the NHS, the NIHR or the Department of Health and Social Care. Acknowledgements Publisher Copyright: © The Author(s), 2021. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists.

Keywords: Severe mental illness, cost, matched cohort study, resource use, type 2 diabetes

Local EPrints ID: 450982

URI: http://eprints.soton.ac.uk/id/eprint/450982

DOI: doi:10.1192/bjp.2021.131

ISSN: 0007-1269

PURE UUID: 5a83a5d0-9c04-495a-bb9b-1cbb67415a13

ORCID for Richard Holt: orcid.org/0000-0001-8911-6744

Date deposited: 31 Aug 2021 16:31

Last modified: 17 Mar 2024 06:47